2024-10-06 - Analysis Report
## HCA Healthcare Inc. (HCA) Stock Analysis

**1. Performance Comparison**

HCA Healthcare Inc. (HCA) is a leading provider of healthcare services in the United States.  HCA has outperformed the S&P 500 (VOO) significantly, with a cumulative return of 319.71% compared to VOO's 131.01%. This results in a divergence of 188.7, placing it at the 93.61% percentile of historical divergence.

**2. Recent Price Movements**

HCA's recent price action shows a short-term downtrend:

* **Closing Price:** $392.46
* **5-Day Moving Average:** $402.47
* **20-Day Moving Average:** $398.58
* **60-Day Moving Average:** $373.39

The stock is currently trading below its short-term moving averages, indicating potential downward pressure.

**3. Technical Indicators**

* **RSI:** 47.35 -  HCA's RSI suggests the stock is in a neutral territory, neither overbought nor oversold. 
* **PPO:** -0.47 -  A negative PPO indicates a bearish trend.
* **Delta_Previous_Relative_Divergence:** -6.39 -  This negative value signifies a recent short-term decline in the stock's relative divergence.
* **Expected Return:** 0.86% -  This indicates a potential 0.86% return over the next 5 years, exceeding the expected return of the S&P 500 (VOO).

**4. Recent Earnings and Outlook**

HCA's recent earnings have been positive, with strong revenue growth. The most recent earnings report for Q2 2024 showed an EPS of $5.6, exceeding analysts' estimates. Revenue reached $17.49 billion, also surpassing expectations. However, the company's earnings have shown a slight dip compared to the previous quarter.

| Date | EPS | Revenue |
|---|---|---|
| 2024-07-29 | $5.6 | $17.49 B |
| 2024-05-02 | $6.01 | $17.34 B |
| 2023-10-26 | $3.98 | $16.21 B |
| 2023-08-02 | $4.35 | $15.86 B |
| 2023-07-29 | $4.35 | $15.86 B |

**5. News and Recent Issues**

The market outlook for HCA is currently mixed. Analysts are cautiously optimistic about the company's future growth potential. They point to HCA's strong market position, robust financial performance, and strategic initiatives to expand its services as positive factors. However, challenges such as inflation, labor shortages, and rising healthcare costs are seen as potential headwinds.

Recent performance highlights include:

* **Strong Q2 2024 Earnings:** HCA exceeded analysts' expectations for both EPS and revenue.
* **Increased Investment in Digital Initiatives:**  HCA is actively investing in digital health technologies to improve patient care and enhance operational efficiency.
* **Acquisition of New Hospitals:** HCA continues to expand its network through strategic acquisitions, further strengthening its market position.

**6. Comprehensive Analysis**

HCA's stock performance has been exceptionally strong, significantly outperforming the market. The company's recent earnings have been positive, with strong revenue growth. However, the stock is currently experiencing some short-term downward pressure. The company faces some challenges, but its strong market position, financial performance, and strategic initiatives indicate long-term potential. 

**7. Conclusion**

HCA Healthcare Inc. (HCA) is a well-established and financially sound company in the healthcare sector. Despite short-term fluctuations, the stock's long-term prospects remain positive. Investors should consider HCA as a potential addition to their portfolio, given its strong performance history and future growth potential. However, it is essential to monitor market conditions, economic indicators, and company-specific developments for a comprehensive assessment of HCA's stock. 
